Back to Journals » OncoTargets and Therapy » Volume 6

Afatinib: emerging next-generation tyrosine kinase inhibitor for NSCLC

Total article views   HTML views PDF downloads Totals
20,647 Dovepress* 12,934+ 3,150 16,084
PubMed Central* 7,713 2,097 9,810
Totals 20,647 5,247 25,894
*Since 5 March 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar